(OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat viral diseases, fibrosis, stroke, dementia, and Alzheimer's disease, announced its ...
As mental health disorders continue to be a mounting issue both state and nationwide, a new research company working to advance clinical trials for behavioral health indications has opened its doors ...